Ný lyf fyrir hrörnun í augbotnum og skylda sjúkdóma

Einar Stefánsson; Morten la Cour; Guðleif Helgadóttir; Haraldur Sigurðsson; Friðbert Jónasson; Gudleif Helgadóttir

Ný lyf fyrir hrörnun í augbotnum og skylda sjúkdóma

Translated title of the contribution: New drug treatment for age-related macular degeneration

Einar Stefánsson
, Morten la Cour
, Guðleif Helgadóttir
, Haraldur Sigurðsson
, Friðbert Jónasson
, Gudleif Helgadóttir

University of Iceland, Landspitali

Research output: Contribution to journal › Article › peer-review

Abstract

New drugs for age-related macular degeneration present a major advance in the treatment of the most common cause of blindness in Iceland. Vascular endothelial growth factor antibodies reduce the risk of blindness and improve vision in patients with age-related macular degeneration.

Translated title of the contribution	New drug treatment for age-related macular degeneration
Original language	Icelandic
Pages (from-to)	299-301
Number of pages	3
Journal	Læknablaðið
Volume	93
Issue number	4
Publication status	Published - Apr 2007

Cite this

@article{de210928795d4fb79128faa05959b8f3,

title = "N{\'y} lyf fyrir hr{\"o}rnun {\'i} augbotnum og skylda sj{\'u}kd{\'o}ma",

abstract = "New drugs for age-related macular degeneration present a major advance in the treatment of the most common cause of blindness in Iceland. Vascular endothelial growth factor antibodies reduce the risk of blindness and improve vision in patients with age-related macular degeneration.",

author = "Einar Stef{\'a}nsson and \{la Cour\}, Morten and Gu{\dh}leif Helgad{\'o}ttir and Haraldur Sigur{\dh}sson and Fri{\dh}bert J{\'o}nasson and Gudleif Helgad{\'o}ttir",

year = "2007",

month = apr,

language = "{\'I}slenska",

volume = "93",

pages = "299--301",

journal = "L{\ae}knabla{\dh}i{\dh}",

issn = "1022-2278",

number = "4",

}

TY - JOUR

T1 - Ný lyf fyrir hrörnun í augbotnum og skylda sjúkdóma

AU - Stefánsson, Einar

AU - la Cour, Morten

AU - Helgadóttir, Guðleif

AU - Sigurðsson, Haraldur

AU - Jónasson, Friðbert

AU - Helgadóttir, Gudleif

PY - 2007/4

Y1 - 2007/4

N2 - New drugs for age-related macular degeneration present a major advance in the treatment of the most common cause of blindness in Iceland. Vascular endothelial growth factor antibodies reduce the risk of blindness and improve vision in patients with age-related macular degeneration.

AB - New drugs for age-related macular degeneration present a major advance in the treatment of the most common cause of blindness in Iceland. Vascular endothelial growth factor antibodies reduce the risk of blindness and improve vision in patients with age-related macular degeneration.

UR - https://www.scopus.com/pages/publications/34250220003

M3 - Grein

C2 - 17460341

SN - 1022-2278

VL - 93

SP - 299

EP - 301

JO - Læknablaðið

JF - Læknablaðið

IS - 4

ER -

Ný lyf fyrir hrörnun í augbotnum og skylda sjúkdóma

Abstract

Fingerprint

Cite this